Coromandel International reported a nearly 25% decline in June-quarter profit despite a 16% rise in revenue, as operating margins came under pressure. The company said the results are not directly comparable with last year following the consolidation of NACL Industries,…
Infosys has also declared the name of Ashiss Kumar Dash as CEO-designate, who will be taking over from Salil Parekh starting April 1, 2027.
NK Proteins expects edible oil prices to remain supported in the near term because of lower domestic crop availability, festive demand and higher import costs. Managing Director Priyam Patel said prices could ease from October as fresh crop arrivals improve…
Anirudh Garg of Invasset PMS says rich small- and mid-cap valuations and global uncertainty have kept the firm on the sidelines. Where will it deploy fresh capital when the opportunity arises? Watch the full interview. Disclaimer: The views and investment…
Chennai Petro’s revenue from operations rose 43.5% sequentially to ₹29,358.8 crore, while total income increased to ₹29,376.5 crore. Profit before tax declined to ₹1,365.6 crore from ₹1,890.4 crore in the preceding quarter as total expenses increased sharply.
Asset quality also improved for Ujjivan Small Finance Bank on a sequential basis. Gross non-performing assets (NPAs) improved to 2.16% from 2.26% sequentially, while net NPA improved to 0.34% from 0.43% in the previous quarter.
The company said its commodity Ibuprofen business continued to weigh on profitability, reporting another quarter of low gross margins and negative EBITDA.
Indo MIM said its metal injection moulding business is operating at around 40% capacity utilisation, providing room to increase production without major capital expenditure. The company said it continues to grow faster than the global MIM industry, supported by exports…
PVR Inox’s board approved the appointment of Shuva Mandal as an additional director in the capacity of an independent director for a five-year term, subject to shareholders’ approval.
Data shows that investors are willing to pay much less for the future profits of life insurance players than what they did about a decade ago. What explains this derating?